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Background: Low-level laser therapy (LLLT) has been shown to modulate the inflammatory process without
adverse effects, by reducing pain and swelling and promoting the repair of damaged tissues. Because pain,
swelling and muscle spasm are complications found in virtually all patients following oral surgery for the removal
of impacted teeth, this model has been widely used to evaluate the effects of LLLT on the inflammatory process
involving bone and, connective tissue and the muscles involved in mastication.
Methods/Design: After meeting the eligibility criteria, 60 patients treated at a Specialty Dental Center for the
removal of impacted lower third molars will be randomly divided into five groups according to the type of laser
therapy used at the end of surgery (intraoral irradiation with 660 nm laser; extraoral irradiation with 660 nm laser;
intraoral irradiation with 808 nm laser; extraoral irradiation with 808 nm laser and no irradiation). To ensure that
patients are blinded to the type of treatment they are receiving, the hand piece of the laser apparatus will be
applied both intraorally and extraorally to all participants, but the device will be turned on only at the appropriate
time, as determined by the randomization process. At 2 and 7 days after surgery, the patients will be evaluated by
three blinded evaluators who will measure of swelling, mouth opening (muscle spasm evaluation) and pain (using
two different pain scales). The 14-item Oral Health Impact Profile (OHIP-14) will be used to assess QOL. All data will
be analyzed with respect to the normality of distribution using the Shapiro-Wilk test. Statistically significant
differences between the experimental groups will be determined using analysis of variance, followed by a suitable
post hoc test, when necessary. The significance level will be set at α = 0.05.
Discussion: The lack of standardization in studies with regard to the samples, methods and LLLT parameters
complicates the determination of the actual effect of laser therapy on this model. The present study aims to
provide a randomized, controlled, double-blind trial to compare four different LLLT parameters in relation to the
outcomes of pain, swelling and muscle spasm following surgery for the extraction of impacted third molars and
evaluate the effects os surgery on patients' quality os life (QOL).
Trial registration: Brazilian Registry of Clinical Trials - Rebec (RBR-6XSB5H).
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Table 1 Scheme for repeated-measures analysis of
variance
Causes of variation Degrees of freedom
Treatment 4
Period 1
Treatment × period 4
Residual 40
Total 49
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Low-level laser therapy (LLLT) has been shown to modu-
late the inflammatory process without adverse effects, by
reducing pain and swelling and promoting the repair of
damaged tissues [1,2]. The effect of LLLT on acute pain
from a soft-tissue injury may be related to the consequent
reduction in edema, hemorrhage, neutrophil infiltration,
inflammatory cytokines and enzymes [3]. The swelling-
reduction effect of LLLT may be related to its ability to
accelerate the regeneration of lymph vessels and decrease
vascular permeability [4-6].
A large number of reports exist regarding the effect of
LLLT on the tissue repair process, especially the inflam-
matory processes that affect muscle tissue [7-10]. How-
ever, studies addressing the effects of LLLT on muscle
spasms caused by the inflammatory process have re-
ported conflicting results [11-17].
Because the removal of impacted third molars involves
damage to bone, and connective tissue and the muscles in-
volved in mastication, this model has been widely used to
evaluate the effect of LLLT on the inflammatory process
[1,18,19]. Indeed, a considerable number of studies have
evaluated the effect of LLLT on reductions in pain, swell-
ing and muscle spasm following the surgical removal of
impacted third molars, but the lack of standardization in
the methods and dosimetric parameters used has compro-
mised evaluation of the desired outcomes and hinders the
acceptance of LLLT as an effective method for minimizing
the adverse effects of third molar surgery [1].
In the literature, eight articles have assessed pain
[11,12,15-17,20-22]. Only studies that used intraoral ap-
plication of red laser irradiation reported a reduction in
postoperative pain, but the parameters were not fully de-
scribed in any of these articles [20,21].
With regard to swelling [11-17,22,23], a reduction in
postoperative edema was obtained in one study that used
red laser (50 mW, 4 J/cm2) applied intraorally [23], one that
used infrared laser (100 mW, 12 J, 4 J/cm2) extraorally [14]
and two that used infrared laser (100 mW, 12 J, 4 J/cm2
and 300 mW, 54 J, respectively) with a combination of
intraoral and extraoral irradiation [13,17].
Concerning muscle spasm [11-17], a reduction was found
in one study that used red laser (300 mW, 10 J/cm2) intrao-
rally [16], two studies that used infrared laser (100 mW, 120
12 J, 4 J/cm2 and 300 mW, 54 J) both intraorally and extrao-
rally [13,17], and one study that used infrared laser
(100 mW, 12 J, 4 J/cm2) either extraorally or intraorally [14].
The aim of the proposed project is to carry out a ran-
domized, controlled, double-blind, clinical trial evalua-
ting the effects of LLLT on pain, swelling and muscle
spasm following surgical removal of impacted third mo-
lars. Comparisons will be made of two sites (intraoral
versus extraoral) and different laser wavelengths (red
versus infrared).Methods/Design
Study location
This randomized, controlled, double-blind, clinical trial will
be carried out in the Specialty Dental Center of the city of
São Bernardo do Campo, state of São Paulo, Brazil.
Study design and composition of study sample
The study design will consist of five treatments evaluated
on two occasions (at 2 and 7 days following surgery).
Table 1 shows the scheme for repeated-measures analysis
of variance. Because the measures of pain, swelling and
mouth opening have low variability when using the pro-
posed scales, 40 degrees of freedom will be sufficient to
control for residual variance. Thus, a minimum sample size
of 50 subjects (10 in each group) is sufficient. Thus 50 pa-
tients undergoing treatment at the center for the removal
of impacted lower third molars will participate in the study.
In addition, as this work predicts a two-factor (two
wavelength), two-group (two irradiation sites) analysis,
there will be 20 patients in each group (10 in each ex-
perimental subgroup) and 20 in control group. The
power analysis (Figure 1) shows that for medium and
large effect size, the test power will remain above 0.8 for
20 subjects in each group.
Ethics approval
The study has received approval from the UNINOVE Hu-
man Research Ethics Committee (protocol number 15410
and 34248) and is registered with both the World Health
Organization (Universal Trial Number U1111-1129-9338)
and the Brazilian Registry of Clinical Trials (RBR-6XSB5H).
Inclusion criteria
Patients undergoing surgical removal of impacted lower
third molars will be included in the study if they agree
to participate after reading and signing a statement of
informed consent.
Exclusion criteria
The exclusion criteria include: presence of systemic disease,
chronic pain or neurological/psychiatric disorder; current
smoking habit; use of anti-inflammatory agent, analgesic or
bisphosphonate drug in the previous 15 days; pericoronitis
Figure 1 The power analysis.
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or history of photosensitivity disorders.
Randomization and composition of groups
After undergoing a clinical evaluation by the dental sur-
geons, patients who meet the eligibility criteria will be
divided into five experimental groups (Figure 2) based on
a randomization method involving raffle numbers.
Randomization will be conducted by a researcher not in-
volved in the recruitment and treatment of the participants.Figure 2 Flowchart characterizing the experimental design, sample coConcealed allocation will be performed using a set of ran-
dom numbers placed in sealed opaque envelopes. The laser
operator will open the envelope containing the procedure
to be performed on each patient immediately following
third molar surgery. Sealed envelopes awaiting new subjects
will be kept in a safe place and given to the operator as the
sessions are scheduled. The 40 patients will be allocated
into four experimental groups or a control group as follows:
Group 1 (660 nm laser, applied intraorally, n = 10), Group 2
(808 nm laser, applied intraorally, n = 10), Group 3 (660 nmmposition, and trial protocol.
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applied extraorally, n = 10), Group 5 (control; no irradi-
ation, n = 20).Blinding procedures
The surgical procedures will be performed by two dental
surgeons and a third person will perform both the pre-
operative evaluation and LLLT. Following a calibration
exercise, three blinded examiners, who have not previ-
ously been involved in the evaluation, surgery or laser
therapy, will perform the postoperative evaluations. The
patients will be unaware of the group to which they are
allocated.Experimental protocol
Preoperative evaluations
Personal data Information on gender (male/female), eth-
nicity (Caucasian, mixed race or African descent), educa-
tion (illiterate to completed postgraduate) and age (years)
will be collected prior to surgery by the laser operator.Table 2 LLLT parameters
Parameter Red laser Infrared laser
Center wavelength [nm] 652 808





Average radiant Power [mW] 100 100
Polarization Random Random
Aperture diameter [cm] 0.094 0.094
Irradiance at aperture [mW/cm2] 3537 3537Surgical difficulty The difficulty of the surgical proce-
dure will be determined based on the Winter Classifica-
tion, the Pell and Gregory classification and the modified
Prant Classification. The Winter Classification [24] con-
siders the alignment of the impacted tooth (vertical, hori-
zontal, mesioangular, disto-angular, horizontal vestibular,
or inverted). The Pell and Gregory scales [25] consider the
position of the tooth on the occlusal plane (on a scale of A
to C) and the ascending ramus of the mandible (on a scale
of 1 to 3). The Prant scale modified by Amarillas-Escobar
et al. [15] classifies the surgical procedure on a five point
scale (grade I - extraction with forceps only, grade II - ex-
traction by osteotomy, grade III - extraction by osteotomy
and coronal section, and grade IV - complex extraction.
At the end of the surgical procedures, the surgeons will
classify the procedures and will record the duration of
each operation from incision to final suture.Beam profile Multimode Multimode
Beam spot size at target [cm2] 0.02827 0.02827
Irradiance at target [mW/cm2] 3537 3537
Exposure duration [s] 30 30
Radiant exposure [J/cm2] 106 106
Radiant energy [J] 3 3
Number of points irradiated 4 4Facial measurements Prior to surgery, the laser operator
will measure and record for each patient the distances
between the corner of the eye and angle of the mandible,
between the tragus and the lip commissure, and between
the tragus and pogonion as described by Amarillas-
Escobar et al. [15].Area irradiated [cm2] 0.113 0.113
Application technique Contact Contact
Number and frequency of treatment
sessions
1 session 1 session
Total radiant energy [J] 12 12Mouth opening Prior to surgery, mouth opening will be
assessed by the laser operator, using a caliper to measure
the distance between the incisal edges of the upper and
lower central incisors as described previously [11,13,14,17].LLLT
Instrument
The Photon Laser III GaAlAs (DMC, São Carlos, São
Paulo, Brazil) will be used. The active medium are a
Arsenide-Gallium-Aluminium and a Indium-Gallium-
Aluminium- Phosphide semiconductor diodes. Emission
is in the red and near -infrared wavelengths, with variable
power values in the continuous emission mode. The
display provides the dosage according to the power and
application time.Irradiation parameters
The laser operator will perform the LLLT for each patient
immediately following third molar surgery using the pa-
rameters given in Table 2.
Intraoral irradiation will be performed by positioning
the laser probe directly in contact with four points on
the gingival mucosa in the area of the surgical field:
point 1, – middle of the bone socket; 2, - the cervical
third of the lingual face; 3, - the middle third of the lin-
gual face; and 4 - apical third of the lingual face. The
laser will be applied for 30 seconds for each point.
Extraoral irradiation will be performed by positioning
the laser probe in contact with the skin on four points of
the masseter muscle: 1 –, lower region (near the mandibu-
lar insertion); 2 –, lower middle region; 3 –, upper middle
region; and 4 –, upper region (near the insertion of the
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30 seconds for each point.
Postoperative evaluations
Evaluation of postoperative pain Because postoperative
pain following third molar extraction reaches its maximum
intensity within 3 to 5 hours, continues for 2 to 3 days and
gradually decreases until the postoperative day 7, this out-
come will be assessed 2 and 7 days following surgery [18]
using a visual analog scale (VAS) and the Numeric Rating
Scale 101 (NRS-101). The VAS is a 10 cm linear scale, ran-
ging from 0 (no pain) to 10 (worst possible pain), while the
NRS-101, measures pain on a scale ranging from 0 (no
pain) and 100 (worst possible pain). The patients will be
instructed by one of the post-surgical evaluators to mark a
point on the VAS, indicating the intensity of the pain
[12,15,22] and for the NRS-101, to attribute a number be-
tween 0 and 100 that best represents the pain they are ex-
periencing [11,20].
Evaluation of postoperative swelling Postoperative
swelling reaches a peak 12 to 48 h following third molar
extraction and begins to decrease during the subsequent
days, disappearing around 5 to 7 days postoperatively
[19,23,26,27]. To measure swelling, most authors meas-
ure the distance between two [11,13,14,23] or three pre-
determined anatomical points on the face [15]. In the
present study, the same three evaluators mentioned
above will measure the distances between the corner of
the eye and angle of the mandible, between the tragus
and lip commissure and between the tragus and pogo-
nion of each patient 2 and 7 days following surgery.
Evaluation of postoperative muscle spasm Spasms in
the muscles of mastication can limit or even prevent
mouth opening following surgical removal of impacted
third molars [11-17]. This outcome is usually assessed
by measuring the distance between the incisal edges of
the upper and lower central incisors using a caliper
[11,13,14,17]. In the present study, the same three evalu-
ators will measure mouth opening in each patient at 2
and 7 days following surgery.
Evaluation of presence and intensity of hematoma/
ecchymosis The presence of hematoma/ecchymosis will
be evaluated by measuring the largest diameter of any color
changes in the skin of the cheek and submandibular region
at 2 and 7 days after surgery. The measure will be per-
formed by the same three evaluators, who will classify the
occurrence of this outcome into four categories: 1) no color
changes; 2) spot diameter of less than 4 cm; 3) spot dia-
meter between 4 and 10 cm; and 4) spot diameter greater
than 10 cm, as described by Bjornsson et al. [28].OHIP-14 questionnaire The 14-item Oral Health Im-
pact Profile (OHIP-14) is a simplified form of the original
OHIP questionnaire used for evaluating of the effect of
oral health status on quality of life (QOL). The items are
classified into the following subscales: functional limita-
tion, pain, psychological discomfort, physical disability,
psychological disability, social disability and handicap. The
questionnaire will be administered to the patients by the
same three evaluators 7 days following surgery.
Patients’ feelings concerning their postoperative status
The same three evaluators will ask the patients the fol-
lowing 10 questions at 2 and 7 days after surgery:
1) Are you maintaining your normal social activities?
2) Are you working/studying normally?
3) Are you maintaining your normal diet?
4) Have you had difficulty swallowing because of the
surgery?
5) Have you had difficulty tasting foods?
6) Can you chew on the operated side?
7) Have you had trouble sleeping because of the
surgery?
8) Have you had difficulty speaking because of the
surgery?
9) Has your appearance changed because of the
surgery?
10) Have you experienced nausea since the surgery?
Evaluation of results
The patients will be evaluated 2 and 7 days after surgery
with regard to the three primary outcomes: pain (VAS
and NRS-101), swelling (comparison of preoperative and
postoperative facial measurements) and muscle spasms
(comparison of preoperative and postoperative mouth
opening). The following data will also be recorded, as
these are frequently analyzed in postoperative evalua-
tions [1,15,24,25,29-33]: degree of surgical difficulty (Pell
and Gregory classification, Winter classification and
modified Prant classification); number of cartridges used
for anesthesia; occurrence of hemorrhage during sur-
gery; duration of surgery (minutes) from initial incision
to final suture; and presence of hematoma/ecchymosis
(largest diameter of color changes in the skin of the
cheek and submandibular region). Individual variables
(gender, ethnicity, educational level and age), OHIP-14
score and effect of surgery on QOL using the 10-item
questionnaire will be evaluated, as suggested by other
authors [29,31-36].
Statistical analysis
All data will be analyzed with respect to the normality of
distribution using the Shapiro-Wilk test. Statistically sig-
nificant differences between the experimental groups
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by a suitable post hoc test, if necessary. The significance
level will be set at α = 0.05. By assuming normality in the
distribution of the data, two-way ANOVA offers a high
power for the design of this trial.
Discussion
Because virtually all patients experience pain, swelling,
and muscle spasm as complications found in virtually all
patients following oral surgery for the removal of bone
and teeth (especially third molars) and these symptoms
have a profound effect on QOL in the first few days after
surgery [29-36] this model has been widely used to
evaluate the effect of LLLT on the inflammatory process
involving bone, connective tissue and the muscles in-
volved in mastication [1,11-17,20-23]. In addition, re-
moval of impacted third molars is one of the most
common procedures in oral surgery [1,34,36]. However,
the lack of standardization in studies with regard to the
samples, methods and LLLT parameters complicates the
determination of the actual effect of laser therapy on this
model [1]. The aim of the present study is to use a ran-
domized, controlled, double-blind trial to compare four
different LLLT parameters in relation to the outcomes of
pain, swelling and muscle spasm following surgery for
the extraction of impacted third molars.
Trial status
At the time of submission of the manuscript, the study
is in the data collection phase.
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